Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ikena Oncology, Inc. - Common Stock (NQ:IKNA)

1.430 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ikena Oncology, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Tuesday's after hours session: top gainers and losers ↗
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 4 Takes On Ikena Oncology ↗
 
Via Benzinga
News headline image
Ikena Oncology: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
IKNA Stock Earnings: Ikena Oncology Beats EPS for Q2 2024 ↗
IKNA stock results show that Ikena Oncology beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Ikena Oncology Discontinues IK-930 Program And Cuts Workforce, Analyst Calls It 'Disappointing' ↗
Ikena Oncology halts its IK-930 program after reviewing clinical data and resources, focusing on the novel MEK-RAF molecular glue, IK-595. 
Via Benzinga
News headline image
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Ikena Oncology: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
Analyst Ratings for Ikena Oncology ↗
 
Via Benzinga
News headline image
This American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time to start the day with a breakdown of the biggest pre-market stock movers traders are going to want to watch on Wednesday morning! 
Via InvestorPlace
News headline image
IKNA Stock Earnings: Ikena Oncology Beats EPS for Q1 2024 ↗
IKNA stock results show that Ikena Oncology beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Ikena Oncology Refocuses on Key Programs: Analysts Maintain Outperform Ratings Amid Strategic Organizational Changes ↗
Ikena Oncology optimizes resources for targeted oncology programs IK-930 & IK-595. Clinical updates expected H2 2024. Workforce reduced by 35%. Financially secure with $175M cash. Strategic focus on... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
Shares of Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) surged in pre-market trading after the company announced its foray into the Middle Ea 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Dow Falls Over 200 Points; Krispy Kreme Reports Downbeat Results ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling over 200 points on Thursday. The Dow traded down 0.71% to 33,871.77 while the NASDAQ fell 0.87% to 13,531.36. The S&P 500... 
Via Benzinga
Topics Stocks
News headline image
Why Is Cancer Firm Ikena Oncology Stock Trading Lower Today? ↗
Ikena Oncology Inc (NASDAQ: IKNA) shared initial data from twenty-six patients treated in the ongoing dose escalation portion of the  
Via Benzinga
News headline image
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings ↗
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded up 0.01% to 34,114.64 while the NASDAQ rose 0.35% to 13,697.53.... 
Via Benzinga
Topics Stocks
News headline image
Optimism Surrounds Cancer Focused Ikena Oncology, Analyst Initiates With Outperform ↗
Ikena Oncology Inc (NASDAQ: IKNA) is garnering attention with its oncology-focused pipeline, and the company's recent developments have raised optimism in the medical community.  
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023 ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're starting off the day with a look at all of the biggest pre-market stock movers worth keeping an eye on for Tuesday! 
Via InvestorPlace
News headline image
Ikena Oncology Acquires Pionyr Immunotherapeutics: Analysts See The Deal As Positive Move ↗
Ikena Oncology Inc (NASDAQ: IKNA) acquired Pionyr Immunotherapeutics Inc, a privately-held biotechnology company, in  
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.